Differing Reactions of Monoclonal Anti-A Antibodies with Oligosaccharides Related to Blood Group A
Overview
Affiliations
Inhibition radioimmunoassays with blood group A-related oligosaccharides have been used to investigate the specificities of six monoclonal anti-A antibodies, three of which had been intentionally generated by immunization of mice with blood group A erythrocytes and A-active blood group substance, and three were incidentally produced following immunization of mice with human tonsil cell membranes or a human colon cancer cell line. By hemagglutination, these antibodies are highly specific for human blood group A erythrocytes. However, they differ from one another in their reaction patterns with mono- and difucosyl A antigen structures and the corresponding afucosyl sequences on Type 1 and Type 2 backbone structures. The six antibodies, together with four previously characterized anti-A monoclonal antibodies (originally raised against the receptor for epidermal growth factor) have been classified into five groups. The first two groups consist of antibodies with broad specificities for A-related structures. There are five antibodies in the first group (TL5, 29.1, A17/3D1, MH2/6D4, and MH1/5D1) reacting to varying degrees with the mono- and difucosyl A antigen structures on either type of backbone sequence. In the second group are two antibodies (A15/3D4 and A15/3D3) which are difficult to inhibit with the oligosaccharides tested, but they reacted best with monofucosyl A structure on either type of backbone. Each of the remaining three antibodies had a distinct and more restricted reaction pattern, with a specificity for the difucosyl A antigen on both types of backbone (antibody EGR/G49) or the Type 1-based mono- and difucosyl A antigen structures (antibody MAS 016c) or the Type 2-based monofucosyl A antigen structure (antibody 455). The reactions of four of the antibodies with N-acetylgalactosamine or with oligosaccharides containing the afucosyl sequence GalNAc alpha 1-3Gal suggest that they may react with certain glycoconjugates with alpha-N-acetylgalactosaminyl termini ("A-like" structures) that are unrelated to the products of the blood group A gene-specified alpha-N-acetylgalactosaminyl-transferase. Knowledge of the differing reactions of these monoclonal antibodies is important for interpreting their reactions with glycoproteins and glycolipids of diverse origins.
Diverse molecular recognition properties of blood group A binding monoclonal antibodies.
Gildersleeve J, Wright W Glycobiology. 2016; 26(5):443-8.
PMID: 26755806 PMC: 4813731. DOI: 10.1093/glycob/cwv171.
Stoll M, Mizuochi T, Childs R, Feizi T Biochem J. 1988; 256(2):661-4.
PMID: 3223939 PMC: 1135460. DOI: 10.1042/bj2560661.
Model-building study of the combining sites of two antibodies to alpha (1----6)dextran.
Padlan E, KABAT E Proc Natl Acad Sci U S A. 1988; 85(18):6885-9.
PMID: 2457920 PMC: 282083. DOI: 10.1073/pnas.85.18.6885.
Okamura Y Histochemistry. 1990; 94(5):489-96.
PMID: 2283312 DOI: 10.1007/BF00272612.
Limas C Am J Pathol. 1991; 139(1):131-7.
PMID: 1713019 PMC: 1886133.